• Immunohistochemistry analysis of paraffin-embedded human tonsil, using TMC8 Antibody. The picture on the right is blocked with the synthesized peptide.
  • Western blot analysis of HeLa cells using TMC8 Polyclonal Antibody. Secondary antibody was diluted at 1:20000

Anti-TMC8 antibody (601-650 aa) (STJ96041)

SKU:
STJ96041

Current Stock:
Host: Rabbit
Applications: WB/IHC/IF/ELISA
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Transmembrane channel-like protein 8 (601-650 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
IHC 1:100-1:300
ELISA 1:5000
IF 1:50-200
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: TMC8
Gene ID: 147138
Uniprot ID: TMC8_HUMAN
Immunogen Region: 601-650 aa
Specificity: TMC8 Polyclonal Antibody detects endogenous levels of TMC8 protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human TMC8 at the amino acid range 601-650
Function Probable ion channel.
Protein Name Transmembrane Channel-Like Protein 8
Epidermodysplasia Verruciformis Protein 2
Cellular Localisation Endoplasmic Reticulum Membrane
Multi-Pass Membrane Protein
Alternative Antibody Names Anti-Transmembrane Channel-Like Protein 8 antibody
Anti-Epidermodysplasia Verruciformis Protein 2 antibody
Anti-TMC8 antibody
Anti-EVER2 antibody
Anti-EVIN2 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance